Abstract:Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with considerable morbidity and mortality. Electrically isolating the pulmonary veins from the left atrium by catheter ablation is superior to antiarrhythmic drug therapy for maintaining sinus rhythm, but its success varies depending on multiple factors, including arrhythmic burden. Although procedural outcomes have improved over the years, further gains are limited by a seemingly zero-sum relationship between effectiveness and safety, which is largely a product of the available technologies. Current energies used to create contiguous, transmural, and durable atrial lesions can result in serious complications if they reach the esophagus or phrenic nerve, for instance—structures that can be adjacent to the atrial myocardium, often within millimeters of the energy source. Consequently, high rates of pulmonary vein-left atrium reconnections are consistently seen in clinical studies and in clinical practice as operators appropriately forgo ablation effectiveness to protect patients from harm. However, as ablative technologies evolve to circumvent this stalemate, safer, and more effective pulmonary vein isolation seems increasingly realistic. Furthermore, the innovative nature of these technologies raises the prospect of markedly improved procedural efficiency, which could increase patient comfort, reduce operator occupational injuries, and enhance the use of health resources—all of which are increasingly important considerations particularly as the demand for catheter ablation for atrial fibrillation continues to rise. We herein review 3 promising candidate ablation technologies with the potential to revolutionize the management of patients with atrial fibrillation: electroporation (pulsed-field ablation), expandable lattice-tip radiofrequency ablation/electroporation, and ultra-low temperature cryoablation.

Contemporary Challenges of Catheter Ablation for Atrial Fibrillation

Current Progress of Computational Modeling for Guiding Clinical Atrial Fibrillation Ablation.

Current Understanding of Atrial Fibrillation Recurrence after Atrial Fibrillation Ablation: from Pulmonary Vein to Epicardium

Catheter ablation for atrial fibrillation: indications and future perspective

Treatment of Long-Standing Persistent Atrial Fibrillation by Linear Ablation

Catheter Ablation of Persistent AF-Where are We Now?

Innovations in atrial fibrillation ablation

Ablating Persistent Atrial Fibrillation Successfully

Transcatheter options for atrial fibrillation treatment: an overview of the ablative techniques currently available and future perspectives

Beyond pulmonary vein isolation: approaches to treat patients with persistent atrial fibrillation

Pearls and Pitfalls in Catheter Ablation of Persistent Atrial Fibrillation

Novel Ablation Catheters for Atrial Fibrillation

Mechanistic Insights From Trials of Atrial Fibrillation Ablation: Charting a Course for the Future

Pulsed Field Ablation to Treat Atrial Fibrillation: A Review of the Literature

Persistent Atrial Fibrillation Ablation: Ongoing Challenges Defining the Target Population and Substrate

Emerging Technologies for Pulmonary Vein Isolation

Pulsed Field Ablation of Atrial Fibrillation: A Novel Technology for Safer and Faster Ablation

Recurrences after Pulsed Field Ablation of Atrial Fibrillation: Incidence, Mechanisms, Predictors, and Comparison with Thermal Energy

A New Hope for the Treatment of Atrial Fibrillation: Application of Pulsed-Field Ablation Technology

Anesthetic Techniques for Ablation in Atrial Fibrillation: A Comparative Review

From Physical Principles to Clinical Applications